The University of Arizona - Arizona Board of Regents was awarded a definitive cost-no-fee contract valued at approximately $7.8 million by the Centers for Disease Control and Prevention to support a prospective cohort study to assess novel approaches. The contract was awarded under the CDC's Coronavirus COVID-19 National Interest Action Code to deliver services in Tucson, Arizona from June 2020 through June 2021. As the prime contractor, the University of Arizona will leverage its expertise in...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $22.4 million definitive contract to the University of Arizona doing business as the Arizona Board of Regents to conduct a prospective cohort study to evaluate the immunogenicity and effectiveness of COVID-19 vaccines among frontline workers. The University of Arizona will serve as the prime contractor and Marshfield Clinic will assist as a subcontractor to evaluate immunogenicity and...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Definitive Contract to the University of Arizona, doing business as the Arizona Board of Regents, for $1,250,000.00 to conduct research on Zika diagnostic testing and vector control. The contract has no set-aside designation. The University of Arizona is a public research university and 1862 land grant institution located in Tucson, Arizona. As a state government entity, higher...
This federal contract award, valued at $267,035.00, was issued by the Centers for Disease Control and Prevention (CDC) to the University of Arizona, doing business as the Arizona Board of Regents. The contract is a definitive, firm-fixed-price contract without a set-aside designation. It covers services related to the contract's "FOR OTHER" description, with a performance location in Tucson, Arizona. The award document indicates that the University of Arizona has extensive capabilities...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $209,409.00 firm fixed price contract to the University of Arizona (doing business as Arizona Board of Regents) for the "Rapid Diagnosis of Coccidioidomycosis". The contract, which does not have a set-aside designation, runs from September 12, 2018 to September 29, 2020. The University of Arizona, a U.S. state government entity, 1862 Land Grant College, Hispanic Serving Institution, and...
This federal contract award, valued at $1,250,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to the University of Arizona, doing business as the Arizona Board of Regents. The contract is for research and development (R&D) services and has a period of performance through April 4, 2025. The contract is a definitive, firm-fixed-price contract, with no set-aside designation. The University of Arizona is a public research university and 1862 land grant institution that...
This is a $349,673 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Arizona, doing business as the Arizona Board of Regents, for a project titled "BAA COVID WASTEWATER". The contract has no set-aside designation and has a period of performance through March 24, 2023. The University of Arizona is a public research university and 1862 land grant institution with expertise across various scientific and technical...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $119,678 firm fixed price contract to the University of Arizona, doing business as the Arizona Board of Regents, for unspecified "OTHER FUNCTIONS REDUCING ANTIBACTERIAL USE". The contract, which does not have a set-aside designation, was awarded on September 30, 2017 and has a completion date of September 29, 2018. The University of Arizona is a U.S. state government entity, 1862 land grant...
This is a $488,326 Firm Fixed Price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Arizona, doing business as the Arizona Board of Regents, for the development and application of automated rockfall recognition capabilities. The contract has an ultimate completion date of August 31, 2024 and was awarded on September 1, 2022. The contract is not set aside for any specific business category. The University of Arizona is a public research...
The University of Arizona, doing business as the Arizona Board of Regents, has been awarded a $2,789,411.92 cost-type delivery order contract by the National Cancer Institute (NCI) to conduct a Phase II randomized, placebo-controlled clinical trial of the prostate cancer vaccine Prostvac (PSA-TRICOM) in patients with clinically localized prostate cancer undergoing active surveillance. This contract supports the NCI's Cancer Prevention Agent Development Program 2012-2017 and does not have a...